Document is current
Any future updates will be listed below
-
Authors
King, Devin A. https://orcid.org/0009-0005-6485-2362
Saxena, Shrishti https://orcid.org/0000-0003-3429-5671
Caefer, Danielle https://orcid.org/0000-0002-3100-4085
Downer, Kyle C.
Saucier, Laura E.
Goodman, Ethan
Aracena, Jonmichael
Zhirova, Alena https://orcid.org/0009-0008-4752-5142
Alchanat, Anthilia https://orcid.org/0009-0006-4529-9482
Nolan, Saoirse
Lokhande, Hrishikesh
Weiner, Howard L.
Gewurz, Benjamin E. https://orcid.org/0000-0002-3965-3418
Chitnis, Tanuja https://orcid.org/0000-0002-9897-4422
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (MS240142)
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 18 August 2026
First Online: 16 September 2026
Ethics
Competing interests: T.C. has received research support from the US Department of Defense, the National Institutes of Health, the National Multiple Sclerosis Society, Genentech Novartis, Octave Biosciences, Sanofi and Tiziana Life Sciences. She has served as a consultant/advisory board member for Genentech, Lilly, Novartis, Octave Biosciences and Sanofi. H.L.W. has received research support from the Cure Alzheimer’s Fund, the National Institutes of Health and the National Multiple Sclerosis Society. He has served on the advisory board for Sanofi and for Tiziana Life Sciences.
